FDA approves Trabectedin (trabectedin) - FDA New Drug Approvals - Nundina

Nundina › Discover calendars › FDA New Drug Approvals calendar › FDA approves Trabectedin (trabectedin)FDA approves Trabectedin (trabectedin)1 October 2026The FDA approved Trabectedin (trabectedin), a drug from Ever. Form: Powder, Intravenous. Application NDA219617.FDA New Drug Approvals calendarMore from this calendar

19 October 2026 - FDA approves Calrezdy (calcuim chloride)

19 October 2026 - FDA approves Cienby (sodium ctirate)

16 October 2026 - FDA approves Yulzety (rivaroxaban)

16 October 2026 - FDA approves Brytly (brytly (apraclonidine))

15 October 2026 - FDA approves Evoxac (cevimeline hydrochloride)